A generic version of a breakthrough cystic fibrosis drug, manufactured in Bangladesh for a fraction of the American price, may give some families around the world an unlikely lifeline. Josua Lottering ...

Please provide your email address to receive an email when new articles are posted on . If purchased through direct-to-consumer pharmacies, 80% of generic drugs with cost sharing of at least $15 would ...

The U.S. Food and Drug Administration granted emergency use authorization for nitenpyram, a medication to treat New World screwworm infestations in dogs and cats. It is the first generic animal drug ...

It’s been three-and-a-half years since generative AI exploded onto the scene. In this past year, progress has continued its relentless pace: Vibe coding took off, companies embraced agentic workflows, ...

In the late 2000s, “mobile-first” emerged as a design discipline. The argument was a single sentence: don’t design for the big screen and squeeze it down. Start with the small screen, the harder ...

The Trump administration on Monday said it is adding generic medications to its direct-to-consumer drug sales website, TrumpRx. The platform, which launched in February, is key to his administration's ...

Using AI chatbots for even just 10 minutes may have a shockingly negative impact on people’s ability to think and problem-solve, according to a new study from researchers at Carnegie Mellon, MIT, ...

Here’s how to invest in custom visuals and turn that content into years of stronger engagement, trust and brand differentiation. Custom visual content builds trust faster by showing real people, ...

A generic version of Wegovy is not currently available in the United States due to patents held by the manufacturer, Novo Nordisk, that may remain in effect until 2041. When the U.S. patent for ...

The era of cheap, officially approved semaglutide is finally here—in Canada, that is. The country has just become the first in North America and the first G7 nation to license a generic version of the ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...